Skip to main content
Equibles

Driehaus Capital Management LLC

Position in NGNE — Neurogene Inc.

CIK 938206 Chicago, IL
Back to NGNE Full portfolio

Position in NGNE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,513,955
+$3,853,413 QoQ
Shares Held
143,528
+338.1% QoQ
Ownership
0.717%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NGNE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. NGNE ranks #52 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5
6,463,551 $241,866,078
6
1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in NGNE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,513,955 143,528
2026-03-31 $660,542 32,765
2025-12-31 $674,959 32,765
2025-09-30 $567,817 32,765
2025-06-30 $489,836 32,765
2025-03-31 $383,678 32,765
2024-12-31 $749,007 32,765
2024-09-30 $4,287,766 102,187
2024-06-30 $3,718,584 102,187
2024-03-31 $2,323,788 45,654